Skip to Content

Pharmaceuticals, Volume 5, Issue 9

2012 September - 10 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (10)

  • Article
  • Open Access
27 Citations
8,869 Views
12 Pages

20 September 2012

The aim of this study is to determine the combined effects of stilbenoids from Shorea gibbosa and vancomycin against methicillin-resistant Staphylococcus aureus (MRSA). A total of nine pure compounds, five stilbenoid dimers ε-viniferin, ampelopsin A,...

  • Review
  • Open Access
12 Citations
7,922 Views
11 Pages

17 September 2012

This mini-review provides the entire experimental history of the development of the old neuroleptic thioridazine (TZ) for therapy of antibiotic resistant pulmonary tuberculosis infections. TZ is effective when used in combination with antibiotics to...

(This article belongs to the Special Issue Antituberculosis Drugs)
  • Review
  • Open Access
20 Citations
9,962 Views
28 Pages

12 September 2012

The development of cancer involves an immense number of factors at the molecular level. These factors are associated principally with alterations in the epigenetic mechanisms that regulate gene expression profiles. Studying the effects of chromatin s...

(This article belongs to the Special Issue Epigenetic Therapies and Biomarkers)
  • Review
  • Open Access
148 Citations
13,812 Views
17 Pages

12 September 2012

Cell-penetrating peptides provide a highly promising strategy for intracellular drug delivery. One relevant clinical application of cell-penetrating peptides is cancer therapeutics. Peptide based delivery could increase the uptake of drugs in tumor c...

(This article belongs to the Special Issue Cell-penetrating Peptides 2012)
  • Review
  • Open Access
60 Citations
9,308 Views
13 Pages

Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer

  • Flora Zagouri,
  • Evangelos Bournakis,
  • Konstantinos Koutsoukos and
  • Christos A. Papadimitriou

12 September 2012

Hsp90 is an abundant protein in mammalian cells. It forms several discrete complexes, each containing distinct groups of co-chaperones that assist protein folding and refolding during stress, protein transport and degradation. It interacts with a var...

(This article belongs to the Special Issue Hsp90 Inhibitors)
  • Review
  • Open Access
2 Citations
8,736 Views
19 Pages

Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design

  • Elisabetta Moroni,
  • Giulia Morra and
  • Giorgio Colombo

10 September 2012

Proteins carry out their functions through interactions with different partners. Dynamic conformational switching among different structural sub-states favors the adaptation to the shapes of the different partners. Such conformational changes can be...

(This article belongs to the Special Issue Hsp90 Inhibitors)
  • Review
  • Open Access
8 Citations
8,835 Views
26 Pages

4 September 2012

Menopause is associated with health concerns including vasomotor symptoms, vulvar/vaginal atrophy (VVA), and osteoporosis. Estrogen therapy or combined estrogen-progestin therapy (EPT) are primary treatment options for menopausal symptom relief and o...

  • Article
  • Open Access
15 Citations
9,637 Views
19 Pages

Differential Cellular and Molecular Effects of Butyrate and Trichostatin A on Vascular Smooth Muscle Cells

  • Shirlette G. Milton,
  • Omana P. Mathew,
  • Frank M. Yatsu and
  • Kasturi Ranganna

4 September 2012

The histone deacetylase (HDAC) inhibitors, butyrate and trichostatin A (TSA), are epigenetic histone modifiers and proliferation inhibitors by downregulating cyclin D1, a positive cell cycle regulator, and upregulating p21Cip1 and INK family of prote...

(This article belongs to the Special Issue Epigenetic Therapies and Biomarkers)
  • Review
  • Open Access
9 Citations
7,924 Views
9 Pages

30 August 2012

In this review, we focus on how inhibitors of Hsp90 can help prevent the resistance to anti-cancer drugs by synergistically increasing their cancer killing abilities and thereby allowing them to function at much lower concentrations than normally use...

(This article belongs to the Special Issue Hsp90 Inhibitors)
XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247